OSE Pharma SA (OSE) — Capital Reinvestment Ratio
OSE Pharma SA (OSE) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow (€66.63 Million) in capital expenditures (€18.00K). Check OSE Pharma SA tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
OSE Pharma SA Capital Reinvestment Ratio (2016–2024)
This chart tracks OSE Pharma SA's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see OSE cash generation efficiency.
Annual Capital Reinvestment Ratio for OSE Pharma SA (2016–2024)
Year-by-year Capital Reinvestment Ratio for OSE Pharma SA from 2016 to 2024. See OSE Pharma SA (OSE) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.00x | €48.44 Million | €77.00K | ▼ -95.8% |
| 2019 | 0.04x | €8.97 Million | €336.00K | ▼ -93.2% |
| 2018 | 0.55x | €1.08 Million | €593.00K | ▲ +1155.4% |
| 2016 | 0.04x | €684.00K | €30.00K | — |